nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosinopril—hypertension—obesity	0.576	1	CtDrD
Fosinopril—ACE—obesity	0.253	1	CbGaD
Fosinopril—ACE—tunica intima—obesity	0.0061	0.217	CbGeAlD
Fosinopril—ACE—sympathetic nervous system—obesity	0.00548	0.195	CbGeAlD
Fosinopril—ACE—autonomic nervous system—obesity	0.00368	0.131	CbGeAlD
Fosinopril—ACE—arm—obesity	0.00325	0.116	CbGeAlD
Fosinopril—ACE—Metabolism of Angiotensinogen to Angiotensins—CPB2—obesity	0.00263	0.124	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—MBOAT4—obesity	0.00102	0.0483	CbGpPWpGaD
Fosinopril—ACE—respiratory system—obesity	0.000948	0.0337	CbGeAlD
Fosinopril—Trandolapril—CES1—obesity	0.000924	0.313	CrCbGaD
Fosinopril—ACE—Peptide hormone metabolism—CPE—obesity	0.000911	0.0431	CbGpPWpGaD
Fosinopril—SLC15A1—digestive system—obesity	0.000841	0.0299	CbGeAlD
Fosinopril—SLC15A2—respiratory system—obesity	0.000826	0.0294	CbGeAlD
Fosinopril—ACE—cardiovascular system—obesity	0.000726	0.0258	CbGeAlD
Fosinopril—SLC15A1—endocrine gland—obesity	0.000695	0.0247	CbGeAlD
Fosinopril—ACE—Peptide hormone metabolism—CPB2—obesity	0.00069	0.0326	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—FFAR4—obesity	0.000659	0.0311	CbGpPWpGaD
Fosinopril—ACE—pituitary gland—obesity	0.000643	0.0229	CbGeAlD
Fosinopril—ACE—adipose tissue—obesity	0.00064	0.0228	CbGeAlD
Fosinopril—SLC15A1—liver—obesity	0.000626	0.0223	CbGeAlD
Fosinopril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC6A14—obesity	0.000612	0.029	CbGpPWpGaD
Fosinopril—ACE—digestive system—obesity	0.000603	0.0215	CbGeAlD
Fosinopril—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—obesity	0.000597	0.0282	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—GH1—obesity	0.000587	0.0278	CbGpPWpGaD
Fosinopril—ACE—adrenal gland—obesity	0.000574	0.0204	CbGeAlD
Fosinopril—ACE—ACE Inhibitor Pathway—AGT—obesity	0.000569	0.0269	CbGpPWpGaD
Fosinopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC6A14—obesity	0.000568	0.0269	CbGpPWpGaD
Fosinopril—SLC15A2—pituitary gland—obesity	0.00056	0.02	CbGeAlD
Fosinopril—SLC15A2—adrenal gland—obesity	0.000501	0.0178	CbGeAlD
Fosinopril—ACE—endocrine gland—obesity	0.000498	0.0177	CbGeAlD
Fosinopril—ACE—Peptide hormone metabolism—DPP4—obesity	0.000479	0.0226	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—GIP—obesity	0.000461	0.0218	CbGpPWpGaD
Fosinopril—ACE—liver—obesity	0.000449	0.016	CbGeAlD
Fosinopril—ACE—Peptide hormone metabolism—PCSK1—obesity	0.000445	0.021	CbGpPWpGaD
Fosinopril—SLC15A2—endocrine gland—obesity	0.000434	0.0155	CbGeAlD
Fosinopril—ACE—ACE Inhibitor Pathway—NOS3—obesity	0.000417	0.0197	CbGpPWpGaD
Fosinopril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC6A14—obesity	0.000361	0.017	CbGpPWpGaD
Fosinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC6A14—obesity	0.000335	0.0158	CbGpPWpGaD
Fosinopril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A3—obesity	0.000299	0.0141	CbGpPWpGaD
Fosinopril—Spirapril—ACE—obesity	0.000291	0.0985	CrCbGaD
Fosinopril—Mitiglinide—PPARG—obesity	0.000278	0.094	CrCbGaD
Fosinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A3—obesity	0.000277	0.0131	CbGpPWpGaD
Fosinopril—ACE—ACE Inhibitor Pathway—TGFB1—obesity	0.000276	0.013	CbGpPWpGaD
Fosinopril—Lisinopril—ACE—obesity	0.000259	0.0878	CrCbGaD
Fosinopril—Cilazapril—ACE—obesity	0.000259	0.0878	CrCbGaD
Fosinopril—ACE—Peptide hormone metabolism—BCHE—obesity	0.000256	0.0121	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—GHRL—obesity	0.000256	0.0121	CbGpPWpGaD
Fosinopril—Ramipril—ACE—obesity	0.000251	0.085	CrCbGaD
Fosinopril—Trandolapril—ACE—obesity	0.000251	0.085	CrCbGaD
Fosinopril—Ramipril—BCHE—obesity	0.000251	0.0848	CrCbGaD
Fosinopril—ACE—Peptide hormone metabolism—TCF7L2—obesity	0.000238	0.0112	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—GCG—obesity	0.000234	0.0111	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC16A7—obesity	0.000213	0.0101	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—GNB3—obesity	0.000201	0.00952	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC16A7—obesity	0.000197	0.00933	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—MBOAT4—obesity	0.000193	0.00912	CbGpPWpGaD
Fosinopril—Enalapril—ACE—obesity	0.00019	0.0644	CrCbGaD
Fosinopril—ACE—Metabolism of proteins—CPE—obesity	0.000172	0.00813	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC6A14—obesity	0.000161	0.00762	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—AGT—obesity	0.000157	0.00742	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—LEP—obesity	0.000154	0.00727	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC6A14—obesity	0.00015	0.00707	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC9A3—obesity	0.000133	0.00631	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—POMC—obesity	0.000132	0.00624	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—INS—obesity	0.000131	0.00621	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—CS—obesity	0.00013	0.00616	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—CPB2—obesity	0.00013	0.00616	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—HK2—obesity	0.000127	0.00602	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—IGF1—obesity	0.000127	0.00601	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—IGFBP2—obesity	0.000124	0.00588	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—FFAR4—obesity	0.000124	0.00588	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC9A3—obesity	0.000124	0.00586	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC27A1—obesity	0.000122	0.00577	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—GFPT1—obesity	0.000119	0.00564	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—HK2—obesity	0.000118	0.00559	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—AQP7—obesity	0.000118	0.00559	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC27A1—obesity	0.000113	0.00536	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—GH1—obesity	0.000111	0.00524	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—AQP7—obesity	0.00011	0.00518	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC16A7—obesity	0.000108	0.00511	CbGpPWpGaD
Fosinopril—Vertigo—Orlistat—obesity	0.000102	0.00086	CcSEcCtD
Fosinopril—Ill-defined disorder—Sibutramine—obesity	0.000102	0.00086	CcSEcCtD
Fosinopril—Hyponatraemia—Topiramate—obesity	0.000102	0.000858	CcSEcCtD
Fosinopril—Anaemia—Sibutramine—obesity	0.000102	0.000856	CcSEcCtD
Fosinopril—Agitation—Sibutramine—obesity	0.000101	0.000852	CcSEcCtD
Fosinopril—Disturbance in sexual arousal—Topiramate—obesity	0.000101	0.000848	CcSEcCtD
Fosinopril—Angioedema—Sibutramine—obesity	0.000101	0.000847	CcSEcCtD
Fosinopril—Palpitations—Orlistat—obesity	0.000101	0.000846	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—LCN2—obesity	0.0001	0.00475	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC16A7—obesity	0.0001	0.00474	CbGpPWpGaD
Fosinopril—Affect lability—Topiramate—obesity	0.0001	0.000841	CcSEcCtD
Fosinopril—Nausea—Cimetidine—obesity	0.0001	0.000841	CcSEcCtD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—HK1—obesity	9.99e-05	0.00473	CbGpPWpGaD
Fosinopril—Malaise—Sibutramine—obesity	9.94e-05	0.000836	CcSEcCtD
Fosinopril—Cough—Orlistat—obesity	9.94e-05	0.000835	CcSEcCtD
Fosinopril—Chills—Bupropion—obesity	9.9e-05	0.000833	CcSEcCtD
Fosinopril—Vertigo—Sibutramine—obesity	9.9e-05	0.000832	CcSEcCtD
Fosinopril—Syncope—Sibutramine—obesity	9.88e-05	0.000831	CcSEcCtD
Fosinopril—Leukopenia—Sibutramine—obesity	9.87e-05	0.000829	CcSEcCtD
Fosinopril—Arrhythmia—Bupropion—obesity	9.86e-05	0.000829	CcSEcCtD
Fosinopril—Palpitations—Sibutramine—obesity	9.74e-05	0.000819	CcSEcCtD
Fosinopril—Chest pain—Orlistat—obesity	9.7e-05	0.000815	CcSEcCtD
Fosinopril—Myalgia—Orlistat—obesity	9.7e-05	0.000815	CcSEcCtD
Fosinopril—Loss of consciousness—Sibutramine—obesity	9.69e-05	0.000814	CcSEcCtD
Fosinopril—Mood swings—Topiramate—obesity	9.63e-05	0.00081	CcSEcCtD
Fosinopril—Cough—Sibutramine—obesity	9.62e-05	0.000809	CcSEcCtD
Fosinopril—Discomfort—Orlistat—obesity	9.58e-05	0.000805	CcSEcCtD
Fosinopril—Blood creatinine increased—Topiramate—obesity	9.52e-05	0.000801	CcSEcCtD
Fosinopril—Hypertension—Sibutramine—obesity	9.52e-05	0.0008	CcSEcCtD
Fosinopril—Dry mouth—Orlistat—obesity	9.48e-05	0.000797	CcSEcCtD
Fosinopril—Flatulence—Bupropion—obesity	9.47e-05	0.000796	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—COX7C—obesity	9.44e-05	0.00447	CbGpPWpGaD
Fosinopril—Tension—Bupropion—obesity	9.43e-05	0.000793	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—STS—obesity	9.42e-05	0.00446	CbGpPWpGaD
Fosinopril—Dysgeusia—Bupropion—obesity	9.41e-05	0.000791	CcSEcCtD
Fosinopril—Chest pain—Sibutramine—obesity	9.38e-05	0.000789	CcSEcCtD
Fosinopril—Arthralgia—Sibutramine—obesity	9.38e-05	0.000789	CcSEcCtD
Fosinopril—Myalgia—Sibutramine—obesity	9.38e-05	0.000789	CcSEcCtD
Fosinopril—Nervousness—Bupropion—obesity	9.33e-05	0.000785	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—LCN2—obesity	9.32e-05	0.00441	CbGpPWpGaD
Fosinopril—Anaphylactic shock—Orlistat—obesity	9.29e-05	0.000781	CcSEcCtD
Fosinopril—Oedema—Orlistat—obesity	9.29e-05	0.000781	CcSEcCtD
Fosinopril—Orthostatic hypotension—Topiramate—obesity	9.28e-05	0.000781	CcSEcCtD
Fosinopril—Abdominal pain upper—Topiramate—obesity	9.28e-05	0.000781	CcSEcCtD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—HK1—obesity	9.27e-05	0.00439	CbGpPWpGaD
Fosinopril—Discomfort—Sibutramine—obesity	9.27e-05	0.000779	CcSEcCtD
Fosinopril—Muscle spasms—Bupropion—obesity	9.24e-05	0.000777	CcSEcCtD
Fosinopril—Infection—Orlistat—obesity	9.23e-05	0.000776	CcSEcCtD
Fosinopril—Breast disorder—Topiramate—obesity	9.19e-05	0.000772	CcSEcCtD
Fosinopril—Dry mouth—Sibutramine—obesity	9.18e-05	0.000772	CcSEcCtD
Fosinopril—Toxic epidermal necrolysis—Topiramate—obesity	9.15e-05	0.00077	CcSEcCtD
Fosinopril—Confusional state—Sibutramine—obesity	9.07e-05	0.000763	CcSEcCtD
Fosinopril—Vision blurred—Bupropion—obesity	9.06e-05	0.000761	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—DPP4—obesity	9.03e-05	0.00427	CbGpPWpGaD
Fosinopril—Tremor—Bupropion—obesity	9e-05	0.000757	CcSEcCtD
Fosinopril—Gastritis—Topiramate—obesity	9e-05	0.000756	CcSEcCtD
Fosinopril—Anaphylactic shock—Sibutramine—obesity	9e-05	0.000756	CcSEcCtD
Fosinopril—Oedema—Sibutramine—obesity	9e-05	0.000756	CcSEcCtD
Fosinopril—Hyperhidrosis—Orlistat—obesity	8.99e-05	0.000755	CcSEcCtD
Fosinopril—Muscular weakness—Topiramate—obesity	8.97e-05	0.000754	CcSEcCtD
Fosinopril—Infection—Sibutramine—obesity	8.94e-05	0.000751	CcSEcCtD
Fosinopril—Ill-defined disorder—Bupropion—obesity	8.92e-05	0.00075	CcSEcCtD
Fosinopril—Anaemia—Bupropion—obesity	8.88e-05	0.000747	CcSEcCtD
Fosinopril—Shock—Sibutramine—obesity	8.85e-05	0.000744	CcSEcCtD
Fosinopril—Abdominal distension—Topiramate—obesity	8.84e-05	0.000744	CcSEcCtD
Fosinopril—Agitation—Bupropion—obesity	8.83e-05	0.000742	CcSEcCtD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC22A1—obesity	8.83e-05	0.00417	CbGpPWpGaD
Fosinopril—Thrombocytopenia—Sibutramine—obesity	8.81e-05	0.00074	CcSEcCtD
Fosinopril—Dysphagia—Topiramate—obesity	8.79e-05	0.000739	CcSEcCtD
Fosinopril—Asthma—Topiramate—obesity	8.79e-05	0.000739	CcSEcCtD
Fosinopril—Angioedema—Bupropion—obesity	8.78e-05	0.000738	CcSEcCtD
Fosinopril—Tachycardia—Sibutramine—obesity	8.78e-05	0.000738	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—COX7C—obesity	8.76e-05	0.00414	CbGpPWpGaD
Fosinopril—Eosinophilia—Topiramate—obesity	8.7e-05	0.000731	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—GIP—obesity	8.7e-05	0.00411	CbGpPWpGaD
Fosinopril—Hyperhidrosis—Sibutramine—obesity	8.7e-05	0.000731	CcSEcCtD
Fosinopril—Malaise—Bupropion—obesity	8.67e-05	0.000728	CcSEcCtD
Fosinopril—Vertigo—Bupropion—obesity	8.63e-05	0.000726	CcSEcCtD
Fosinopril—Syncope—Bupropion—obesity	8.62e-05	0.000724	CcSEcCtD
Fosinopril—Pancreatitis—Topiramate—obesity	8.61e-05	0.000724	CcSEcCtD
Fosinopril—Leukopenia—Bupropion—obesity	8.6e-05	0.000723	CcSEcCtD
Fosinopril—Anorexia—Sibutramine—obesity	8.57e-05	0.000721	CcSEcCtD
Fosinopril—Sweating increased—Topiramate—obesity	8.56e-05	0.000719	CcSEcCtD
Fosinopril—Angina pectoris—Topiramate—obesity	8.56e-05	0.000719	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—FTL—obesity	8.54e-05	0.00404	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—GABRA6—obesity	8.54e-05	0.00404	CbGpPWpGaD
Fosinopril—Palpitations—Bupropion—obesity	8.49e-05	0.000714	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Orlistat—obesity	8.47e-05	0.000712	CcSEcCtD
Fosinopril—Loss of consciousness—Bupropion—obesity	8.45e-05	0.00071	CcSEcCtD
Fosinopril—Insomnia—Orlistat—obesity	8.41e-05	0.000707	CcSEcCtD
Fosinopril—Hypotension—Sibutramine—obesity	8.41e-05	0.000707	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—PCSK1—obesity	8.4e-05	0.00397	CbGpPWpGaD
Fosinopril—Cough—Bupropion—obesity	8.38e-05	0.000705	CcSEcCtD
Fosinopril—Paraesthesia—Orlistat—obesity	8.35e-05	0.000702	CcSEcCtD
Fosinopril—Pancytopenia—Topiramate—obesity	8.34e-05	0.000701	CcSEcCtD
Fosinopril—Hypertension—Bupropion—obesity	8.3e-05	0.000697	CcSEcCtD
Fosinopril—Neutropenia—Topiramate—obesity	8.22e-05	0.000691	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Sibutramine—obesity	8.2e-05	0.000689	CcSEcCtD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC22A1—obesity	8.19e-05	0.00387	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC6A14—obesity	8.19e-05	0.00387	CbGpPWpGaD
Fosinopril—Dyspepsia—Orlistat—obesity	8.18e-05	0.000688	CcSEcCtD
Fosinopril—Arthralgia—Bupropion—obesity	8.18e-05	0.000688	CcSEcCtD
Fosinopril—Chest pain—Bupropion—obesity	8.18e-05	0.000688	CcSEcCtD
Fosinopril—Myalgia—Bupropion—obesity	8.18e-05	0.000688	CcSEcCtD
Fosinopril—Upper respiratory tract infection—Topiramate—obesity	8.17e-05	0.000686	CcSEcCtD
Fosinopril—Insomnia—Sibutramine—obesity	8.14e-05	0.000684	CcSEcCtD
Fosinopril—Pollakiuria—Topiramate—obesity	8.12e-05	0.000682	CcSEcCtD
Fosinopril—Erectile dysfunction—Topiramate—obesity	8.09e-05	0.00068	CcSEcCtD
Fosinopril—Discomfort—Bupropion—obesity	8.08e-05	0.000679	CcSEcCtD
Fosinopril—Decreased appetite—Orlistat—obesity	8.08e-05	0.000679	CcSEcCtD
Fosinopril—Paraesthesia—Sibutramine—obesity	8.08e-05	0.000679	CcSEcCtD
Fosinopril—Dyspnoea—Sibutramine—obesity	8.02e-05	0.000674	CcSEcCtD
Fosinopril—Photosensitivity reaction—Topiramate—obesity	8.02e-05	0.000674	CcSEcCtD
Fosinopril—Fatigue—Orlistat—obesity	8.01e-05	0.000674	CcSEcCtD
Fosinopril—Dry mouth—Bupropion—obesity	8e-05	0.000673	CcSEcCtD
Fosinopril—Somnolence—Sibutramine—obesity	8e-05	0.000672	CcSEcCtD
Fosinopril—Weight increased—Topiramate—obesity	8e-05	0.000672	CcSEcCtD
Fosinopril—Weight decreased—Topiramate—obesity	7.95e-05	0.000668	CcSEcCtD
Fosinopril—Pain—Orlistat—obesity	7.95e-05	0.000668	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—GABRA6—obesity	7.93e-05	0.00375	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—FTL—obesity	7.93e-05	0.00375	CbGpPWpGaD
Fosinopril—Dyspepsia—Sibutramine—obesity	7.92e-05	0.000666	CcSEcCtD
Fosinopril—Confusional state—Bupropion—obesity	7.91e-05	0.000665	CcSEcCtD
Fosinopril—Pneumonia—Topiramate—obesity	7.88e-05	0.000662	CcSEcCtD
Fosinopril—Oedema—Bupropion—obesity	7.84e-05	0.000659	CcSEcCtD
Fosinopril—Anaphylactic shock—Bupropion—obesity	7.84e-05	0.000659	CcSEcCtD
Fosinopril—Decreased appetite—Sibutramine—obesity	7.82e-05	0.000657	CcSEcCtD
Fosinopril—Infection—Bupropion—obesity	7.79e-05	0.000655	CcSEcCtD
Fosinopril—Stevens-Johnson syndrome—Topiramate—obesity	7.77e-05	0.000653	CcSEcCtD
Fosinopril—Shock—Bupropion—obesity	7.72e-05	0.000649	CcSEcCtD
Fosinopril—Renal failure—Topiramate—obesity	7.7e-05	0.000647	CcSEcCtD
Fosinopril—Pain—Sibutramine—obesity	7.69e-05	0.000647	CcSEcCtD
Fosinopril—Constipation—Sibutramine—obesity	7.69e-05	0.000647	CcSEcCtD
Fosinopril—Neuropathy peripheral—Topiramate—obesity	7.68e-05	0.000646	CcSEcCtD
Fosinopril—Thrombocytopenia—Bupropion—obesity	7.68e-05	0.000645	CcSEcCtD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—GCK—obesity	7.67e-05	0.00363	CbGpPWpGaD
Fosinopril—Feeling abnormal—Orlistat—obesity	7.66e-05	0.000644	CcSEcCtD
Fosinopril—Tachycardia—Bupropion—obesity	7.65e-05	0.000643	CcSEcCtD
Fosinopril—Gastrointestinal pain—Orlistat—obesity	7.6e-05	0.000639	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC6A14—obesity	7.6e-05	0.00359	CbGpPWpGaD
Fosinopril—Hyperhidrosis—Bupropion—obesity	7.58e-05	0.000637	CcSEcCtD
Fosinopril—Anorexia—Bupropion—obesity	7.48e-05	0.000628	CcSEcCtD
Fosinopril—Feeling abnormal—Sibutramine—obesity	7.41e-05	0.000623	CcSEcCtD
Fosinopril—Epistaxis—Topiramate—obesity	7.39e-05	0.000621	CcSEcCtD
Fosinopril—Urticaria—Orlistat—obesity	7.38e-05	0.000621	CcSEcCtD
Fosinopril—Gastrointestinal pain—Sibutramine—obesity	7.36e-05	0.000618	CcSEcCtD
Fosinopril—Sinusitis—Topiramate—obesity	7.35e-05	0.000618	CcSEcCtD
Fosinopril—Body temperature increased—Orlistat—obesity	7.35e-05	0.000618	CcSEcCtD
Fosinopril—Abdominal pain—Orlistat—obesity	7.35e-05	0.000618	CcSEcCtD
Fosinopril—Hypotension—Bupropion—obesity	7.33e-05	0.000616	CcSEcCtD
Fosinopril—Agranulocytosis—Topiramate—obesity	7.31e-05	0.000615	CcSEcCtD
Fosinopril—Bradycardia—Topiramate—obesity	7.16e-05	0.000602	CcSEcCtD
Fosinopril—Urticaria—Sibutramine—obesity	7.15e-05	0.000601	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Bupropion—obesity	7.14e-05	0.000601	CcSEcCtD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—GCK—obesity	7.12e-05	0.00337	CbGpPWpGaD
Fosinopril—Body temperature increased—Sibutramine—obesity	7.11e-05	0.000598	CcSEcCtD
Fosinopril—Abdominal pain—Sibutramine—obesity	7.11e-05	0.000598	CcSEcCtD
Fosinopril—Insomnia—Bupropion—obesity	7.09e-05	0.000596	CcSEcCtD
Fosinopril—Haemoglobin—Topiramate—obesity	7.07e-05	0.000594	CcSEcCtD
Fosinopril—Rhinitis—Topiramate—obesity	7.05e-05	0.000593	CcSEcCtD
Fosinopril—Paraesthesia—Bupropion—obesity	7.04e-05	0.000592	CcSEcCtD
Fosinopril—Hepatitis—Topiramate—obesity	7.03e-05	0.000591	CcSEcCtD
Fosinopril—Haemorrhage—Topiramate—obesity	7.03e-05	0.000591	CcSEcCtD
Fosinopril—Hallucination—Topiramate—obesity	7e-05	0.000588	CcSEcCtD
Fosinopril—Hypoaesthesia—Topiramate—obesity	7e-05	0.000588	CcSEcCtD
Fosinopril—Dyspnoea—Bupropion—obesity	6.99e-05	0.000588	CcSEcCtD
Fosinopril—Pharyngitis—Topiramate—obesity	6.98e-05	0.000587	CcSEcCtD
Fosinopril—Somnolence—Bupropion—obesity	6.97e-05	0.000586	CcSEcCtD
Fosinopril—Oedema peripheral—Topiramate—obesity	6.93e-05	0.000582	CcSEcCtD
Fosinopril—Dyspepsia—Bupropion—obesity	6.9e-05	0.00058	CcSEcCtD
Fosinopril—Hypersensitivity—Orlistat—obesity	6.85e-05	0.000576	CcSEcCtD
Fosinopril—Decreased appetite—Bupropion—obesity	6.82e-05	0.000573	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC9A3—obesity	6.78e-05	0.00321	CbGpPWpGaD
Fosinopril—Visual impairment—Topiramate—obesity	6.78e-05	0.00057	CcSEcCtD
Fosinopril—Fatigue—Bupropion—obesity	6.76e-05	0.000568	CcSEcCtD
Fosinopril—Pain—Bupropion—obesity	6.71e-05	0.000564	CcSEcCtD
Fosinopril—Constipation—Bupropion—obesity	6.71e-05	0.000564	CcSEcCtD
Fosinopril—Asthenia—Orlistat—obesity	6.67e-05	0.000561	CcSEcCtD
Fosinopril—Erythema multiforme—Topiramate—obesity	6.65e-05	0.000559	CcSEcCtD
Fosinopril—Hypersensitivity—Sibutramine—obesity	6.63e-05	0.000557	CcSEcCtD
Fosinopril—Pruritus—Orlistat—obesity	6.58e-05	0.000553	CcSEcCtD
Fosinopril—Tinnitus—Topiramate—obesity	6.56e-05	0.000551	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—IGFBP1—obesity	6.53e-05	0.00309	CbGpPWpGaD
Fosinopril—Flushing—Topiramate—obesity	6.53e-05	0.000549	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—HK2—obesity	6.47e-05	0.00306	CbGpPWpGaD
Fosinopril—Feeling abnormal—Bupropion—obesity	6.46e-05	0.000543	CcSEcCtD
Fosinopril—Asthenia—Sibutramine—obesity	6.45e-05	0.000543	CcSEcCtD
Fosinopril—Gastrointestinal pain—Bupropion—obesity	6.41e-05	0.000539	CcSEcCtD
Fosinopril—Pruritus—Sibutramine—obesity	6.36e-05	0.000535	CcSEcCtD
Fosinopril—Diarrhoea—Orlistat—obesity	6.36e-05	0.000535	CcSEcCtD
Fosinopril—Chills—Topiramate—obesity	6.31e-05	0.00053	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC9A3—obesity	6.3e-05	0.00298	CbGpPWpGaD
Fosinopril—Urticaria—Bupropion—obesity	6.23e-05	0.000524	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC27A1—obesity	6.2e-05	0.00293	CbGpPWpGaD
Fosinopril—Abdominal pain—Bupropion—obesity	6.2e-05	0.000521	CcSEcCtD
Fosinopril—Body temperature increased—Bupropion—obesity	6.2e-05	0.000521	CcSEcCtD
Fosinopril—Diarrhoea—Sibutramine—obesity	6.15e-05	0.000517	CcSEcCtD
Fosinopril—Dizziness—Orlistat—obesity	6.15e-05	0.000517	CcSEcCtD
Fosinopril—Flatulence—Topiramate—obesity	6.03e-05	0.000507	CcSEcCtD
Fosinopril—Tension—Topiramate—obesity	6.01e-05	0.000505	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—HK2—obesity	6.01e-05	0.00284	CbGpPWpGaD
Fosinopril—Dysgeusia—Topiramate—obesity	5.99e-05	0.000504	CcSEcCtD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—obesity	5.96e-05	0.00282	CbGpPWpGaD
Fosinopril—Dizziness—Sibutramine—obesity	5.95e-05	0.0005	CcSEcCtD
Fosinopril—Nervousness—Topiramate—obesity	5.95e-05	0.0005	CcSEcCtD
Fosinopril—Vomiting—Orlistat—obesity	5.91e-05	0.000497	CcSEcCtD
Fosinopril—Muscle spasms—Topiramate—obesity	5.89e-05	0.000495	CcSEcCtD
Fosinopril—Rash—Orlistat—obesity	5.86e-05	0.000493	CcSEcCtD
Fosinopril—Dermatitis—Orlistat—obesity	5.86e-05	0.000492	CcSEcCtD
Fosinopril—Headache—Orlistat—obesity	5.82e-05	0.00049	CcSEcCtD
Fosinopril—Hypersensitivity—Bupropion—obesity	5.78e-05	0.000486	CcSEcCtD
Fosinopril—Vision blurred—Topiramate—obesity	5.77e-05	0.000485	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC27A1—obesity	5.76e-05	0.00272	CbGpPWpGaD
Fosinopril—Tremor—Topiramate—obesity	5.74e-05	0.000482	CcSEcCtD
Fosinopril—Vomiting—Sibutramine—obesity	5.72e-05	0.000481	CcSEcCtD
Fosinopril—Ill-defined disorder—Topiramate—obesity	5.68e-05	0.000478	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—IGFBP3—obesity	5.67e-05	0.00268	CbGpPWpGaD
Fosinopril—Rash—Sibutramine—obesity	5.67e-05	0.000477	CcSEcCtD
Fosinopril—Dermatitis—Sibutramine—obesity	5.67e-05	0.000476	CcSEcCtD
Fosinopril—Anaemia—Topiramate—obesity	5.66e-05	0.000476	CcSEcCtD
Fosinopril—Headache—Sibutramine—obesity	5.64e-05	0.000474	CcSEcCtD
Fosinopril—Asthenia—Bupropion—obesity	5.63e-05	0.000473	CcSEcCtD
Fosinopril—Agitation—Topiramate—obesity	5.63e-05	0.000473	CcSEcCtD
Fosinopril—Pruritus—Bupropion—obesity	5.55e-05	0.000466	CcSEcCtD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—obesity	5.53e-05	0.00262	CbGpPWpGaD
Fosinopril—Nausea—Orlistat—obesity	5.52e-05	0.000464	CcSEcCtD
Fosinopril—Malaise—Topiramate—obesity	5.52e-05	0.000464	CcSEcCtD
Fosinopril—Vertigo—Topiramate—obesity	5.5e-05	0.000462	CcSEcCtD
Fosinopril—Syncope—Topiramate—obesity	5.49e-05	0.000462	CcSEcCtD
Fosinopril—Leukopenia—Topiramate—obesity	5.48e-05	0.000461	CcSEcCtD
Fosinopril—Palpitations—Topiramate—obesity	5.41e-05	0.000455	CcSEcCtD
Fosinopril—Loss of consciousness—Topiramate—obesity	5.38e-05	0.000452	CcSEcCtD
Fosinopril—Diarrhoea—Bupropion—obesity	5.37e-05	0.000451	CcSEcCtD
Fosinopril—Nausea—Sibutramine—obesity	5.34e-05	0.000449	CcSEcCtD
Fosinopril—Cough—Topiramate—obesity	5.34e-05	0.000449	CcSEcCtD
Fosinopril—Hypertension—Topiramate—obesity	5.29e-05	0.000444	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—TRPV1—obesity	5.28e-05	0.00249	CbGpPWpGaD
Fosinopril—Arthralgia—Topiramate—obesity	5.21e-05	0.000438	CcSEcCtD
Fosinopril—Myalgia—Topiramate—obesity	5.21e-05	0.000438	CcSEcCtD
Fosinopril—Chest pain—Topiramate—obesity	5.21e-05	0.000438	CcSEcCtD
Fosinopril—Dizziness—Bupropion—obesity	5.19e-05	0.000436	CcSEcCtD
Fosinopril—Discomfort—Topiramate—obesity	5.15e-05	0.000433	CcSEcCtD
Fosinopril—Dry mouth—Topiramate—obesity	5.1e-05	0.000429	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—HK1—obesity	5.08e-05	0.0024	CbGpPWpGaD
Fosinopril—Confusional state—Topiramate—obesity	5.04e-05	0.000424	CcSEcCtD
Fosinopril—Oedema—Topiramate—obesity	5e-05	0.00042	CcSEcCtD
Fosinopril—Vomiting—Bupropion—obesity	4.99e-05	0.000419	CcSEcCtD
Fosinopril—Infection—Topiramate—obesity	4.96e-05	0.000417	CcSEcCtD
Fosinopril—Rash—Bupropion—obesity	4.94e-05	0.000416	CcSEcCtD
Fosinopril—Dermatitis—Bupropion—obesity	4.94e-05	0.000415	CcSEcCtD
Fosinopril—Shock—Topiramate—obesity	4.92e-05	0.000413	CcSEcCtD
Fosinopril—Headache—Bupropion—obesity	4.91e-05	0.000413	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—TRPV1—obesity	4.9e-05	0.00232	CbGpPWpGaD
Fosinopril—Thrombocytopenia—Topiramate—obesity	4.89e-05	0.000411	CcSEcCtD
Fosinopril—Tachycardia—Topiramate—obesity	4.88e-05	0.00041	CcSEcCtD
Fosinopril—Hyperhidrosis—Topiramate—obesity	4.83e-05	0.000406	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—GHRL—obesity	4.82e-05	0.00228	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—BCHE—obesity	4.82e-05	0.00228	CbGpPWpGaD
Fosinopril—Anorexia—Topiramate—obesity	4.76e-05	0.0004	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—HK1—obesity	4.71e-05	0.00223	CbGpPWpGaD
Fosinopril—Hypotension—Topiramate—obesity	4.67e-05	0.000392	CcSEcCtD
Fosinopril—Nausea—Bupropion—obesity	4.66e-05	0.000392	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Topiramate—obesity	4.55e-05	0.000383	CcSEcCtD
Fosinopril—Insomnia—Topiramate—obesity	4.52e-05	0.00038	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—TCF7L2—obesity	4.49e-05	0.00212	CbGpPWpGaD
Fosinopril—Paraesthesia—Topiramate—obesity	4.49e-05	0.000377	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC22A1—obesity	4.49e-05	0.00212	CbGpPWpGaD
Fosinopril—Dyspnoea—Topiramate—obesity	4.45e-05	0.000374	CcSEcCtD
Fosinopril—Somnolence—Topiramate—obesity	4.44e-05	0.000373	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—GCG—obesity	4.41e-05	0.00209	CbGpPWpGaD
Fosinopril—Dyspepsia—Topiramate—obesity	4.4e-05	0.00037	CcSEcCtD
Fosinopril—Decreased appetite—Topiramate—obesity	4.34e-05	0.000365	CcSEcCtD
Fosinopril—Fatigue—Topiramate—obesity	4.31e-05	0.000362	CcSEcCtD
Fosinopril—Constipation—Topiramate—obesity	4.27e-05	0.000359	CcSEcCtD
Fosinopril—Pain—Topiramate—obesity	4.27e-05	0.000359	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC22A1—obesity	4.16e-05	0.00197	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—PRKAR2B—obesity	4.14e-05	0.00196	CbGpPWpGaD
Fosinopril—Feeling abnormal—Topiramate—obesity	4.12e-05	0.000346	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—PLG—obesity	4.1e-05	0.00194	CbGpPWpGaD
Fosinopril—Gastrointestinal pain—Topiramate—obesity	4.09e-05	0.000343	CcSEcCtD
Fosinopril—Urticaria—Topiramate—obesity	3.97e-05	0.000334	CcSEcCtD
Fosinopril—Body temperature increased—Topiramate—obesity	3.95e-05	0.000332	CcSEcCtD
Fosinopril—Abdominal pain—Topiramate—obesity	3.95e-05	0.000332	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—GCK—obesity	3.9e-05	0.00184	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—PRKAR2B—obesity	3.84e-05	0.00182	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—GNB3—obesity	3.8e-05	0.0018	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—CETP—obesity	3.76e-05	0.00178	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—IGF2—obesity	3.73e-05	0.00177	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—TF—obesity	3.72e-05	0.00176	CbGpPWpGaD
Fosinopril—Hypersensitivity—Topiramate—obesity	3.68e-05	0.000309	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—GCK—obesity	3.62e-05	0.00171	CbGpPWpGaD
Fosinopril—Asthenia—Topiramate—obesity	3.58e-05	0.000301	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—TFRC—obesity	3.56e-05	0.00169	CbGpPWpGaD
Fosinopril—Pruritus—Topiramate—obesity	3.53e-05	0.000297	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—CETP—obesity	3.49e-05	0.00165	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—TF—obesity	3.45e-05	0.00163	CbGpPWpGaD
Fosinopril—Diarrhoea—Topiramate—obesity	3.42e-05	0.000287	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—TFRC—obesity	3.31e-05	0.00156	CbGpPWpGaD
Fosinopril—Dizziness—Topiramate—obesity	3.3e-05	0.000278	CcSEcCtD
Fosinopril—Vomiting—Topiramate—obesity	3.18e-05	0.000267	CcSEcCtD
Fosinopril—Rash—Topiramate—obesity	3.15e-05	0.000265	CcSEcCtD
Fosinopril—Dermatitis—Topiramate—obesity	3.15e-05	0.000265	CcSEcCtD
Fosinopril—Headache—Topiramate—obesity	3.13e-05	0.000263	CcSEcCtD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—ALB—obesity	3.07e-05	0.00145	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC2A4—obesity	3.03e-05	0.00143	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—CYCS—obesity	2.99e-05	0.00141	CbGpPWpGaD
Fosinopril—Nausea—Topiramate—obesity	2.97e-05	0.000249	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—AGT—obesity	2.96e-05	0.0014	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—LEP—obesity	2.9e-05	0.00137	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—NCOA1—obesity	2.89e-05	0.00137	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—obesity	2.85e-05	0.00135	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—PLG—obesity	2.82e-05	0.00133	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A4—obesity	2.81e-05	0.00133	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—CYCS—obesity	2.78e-05	0.00131	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—F2—obesity	2.74e-05	0.00129	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—NCOA1—obesity	2.68e-05	0.00127	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—PLG—obesity	2.61e-05	0.00124	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—GNB3—obesity	2.61e-05	0.00123	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—HMOX1—obesity	2.6e-05	0.00123	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—GNAS—obesity	2.54e-05	0.0012	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—POMC—obesity	2.49e-05	0.00118	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—APOB—obesity	2.49e-05	0.00118	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—INS—obesity	2.48e-05	0.00117	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—CCL2—obesity	2.44e-05	0.00115	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—GNB3—obesity	2.42e-05	0.00115	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—HMOX1—obesity	2.41e-05	0.00114	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—IGF1—obesity	2.4e-05	0.00113	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—GNAS—obesity	2.36e-05	0.00112	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—APOB—obesity	2.31e-05	0.00109	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—PPARA—obesity	2.1e-05	0.000993	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—APOA1—obesity	1.97e-05	0.000932	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—PPARA—obesity	1.95e-05	0.000922	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—APOA1—obesity	1.83e-05	0.000865	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ALB—obesity	1.56e-05	0.000738	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ALB—obesity	1.45e-05	0.000685	CbGpPWpGaD
